Immunohistochemistry analysis of the proliferation marker Ki67 indicates an increase in the number of Ki67-positive staining in control (DMSO)-treated spheroid slices compared to SAL-treated ones (figure 6C and D), supporting a tumor suppressive mechanism by SAL. This evidence concerns the gene MKI67 and neoplasm.